Options Trading News

July 12, 2013  Fri 7:28 AM CT

Revenue Also Better Than Consensus

WebMD Health said it now expects to report second-quarter profit of $0.05 a share, while previously it had forecast a loss. Revenue of $124 million to $125 million is also well above the $117 million consensus number. WBMD, which cited strong ad demand from biopharmaceutical customers, rose almost 19 percent before the opening bell on my tradeMONSTER platform.

Spreadtrum Accepted Sweetened Bid

Chinese semiconductor company Spreadtrum Communications shot higher on a takeover bid last month, and now it's accepted a sweetened offer. This time Tsinghua Holdings agreed to pay $31 a share, up from $28.50 previously. SPRD gains 17 percent in the premarket.

More Bad News For Aveo Pharma

The Securities and Exchange Commission has subpoenaed Aveo Pharmaceuticals over its tivozanib kidney drug. That's adding insult to injury for a company that's already lost two-thirds of its value this year after the product failed to extend patients' lives! AVEO drops almost 13 percent in early trading.
Share this article with your friends

Invest Like a Monster - San Antonio: October 9-10

Premium Services

Archived Webinar

Education & Strategy

The covered call and unhedged risk

I have written a few things on the Covered Call Strategy over the last two weeks. Please understand that those two previous articles plus this one do not constitute a proper, fully in-depth lesson on the Covered Call Strategy like we have in our classes at Option Monster Education. I have picked out a few topics that I believe were worth noting and today I am going to add the final one.

View more education articles »